Advances in the adjuvant and neoadjuvant treatment of breast cancer

被引：1

作者：

Briest, Susanne ^{[1
,2
]}

Stearns, Vered ^{[2
]}

机构：

[1] Univ Leipzig, Dept Gynecol & Obstet, Leipzig, Germany

[2] Johns Hopkins Sch Med, Sidney Kimmel Comprehens Canc Ctr, 1650 Orleans St,CRB 1,Room 1M-53, Baltimore, MD 21231 USA

来源：

WOMENS HEALTH | 2007年 / 3卷 / 03期

关键词：

adjuvant treatment; aromatase inhibitors; breast cancer; chemotherapy; hormonal therapy; neoadjuvant treatment; trastuzumab;

D O I：

10.2217/17455057.3.3.325

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

Several advances in the adjuvant systemic therapy of primary breast cancer have occurred in the last decade and contributed to a decline in disease-related mortality. These include the introduction of aromatase inhibitors, new chemotherapy agents, and the novel antibody trastuzumab. New supportive treatments, such as growth factors, have contributed to the optimization of chemotherapy dose and schedule, and have improved the efficacy and safety of the treatment. In this review we will outline some of the recent advances in the adjuvant and neoadjuvant treatment of breast cancer. We will also discuss ongoing and proposed clinical trials.

引用

页码：325 / 339

页数：15

共 73 条

[1]

Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0

[2] Estrogen receptor breast cancer phenotypes in the surveillance, epidemiology, and end results database [J].

Anderson, WF ;

Chatterjee, N ;

Ershler, WB ;

Brawley, OW .

BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 (01) :27-36

[3] Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-27 [J].

Bear, HD ;

Anderson, S ;

Smith, RE ;

Geyer, CE ;

Mamounas, EP ;

Fisher, B ;

Brown, AM ;

Robidoux, A ;

Margolese, R ;

Kahlenberg, MS ;

Paik, S ;

Soran, A ;

Wickerham, DL ;

Wolmark, N .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (13) :2019-2027

[4] The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: Preliminary results from national surgical adjuvant breast and bowel project protocol B-27 [J].

Bear, HD ;

Anderson, S ;

Brown, A ;

Smith, R ;

Mamounas, EP ;

Fisher, B ;

Margolese, R ;

Theoret, H ;

Soran, A ;

Wickerham, DL ;

Wolmark, N .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (22) :4165-4174

[5]

Beatson G.T., 1896, LANCET, V148, P101

[6]

BERNARDI A, 2002, P AN M AM SOC CLIN, V21, P217

[7] Adjuvant chemotherapy followed by Goserelin compared with either modality alone:: The impact on amenorrhea, hot flashes, and quality of life in premenopausal patients -: The International Breast Cancer Study Group trial VIII [J].

Bernhard, Juerg ;

Zahrieh, David ;

Castiglione-Gertsch, Monica ;

Huerny, Christoph ;

Gelber, Richard D. ;

Forbes, John F. ;

Murray, Elizabeth ;

Collins, John ;

Aebi, Stefan ;

Thuerlimann, Beat ;

Price, Karen N. ;

Goldhirsch, Aron ;

Coates, Alan S. .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (03) :263-270

[8] Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer [J].

Berry, DA ;

Cirrincione, C ;

Henderson, IC ;

Citron, ML ;

Budman, DR ;

Goldstein, LJ ;

Martino, S ;

Perez, EA ;

Muss, HB ;

Norton, L ;

Hudis, C ;

Winer, EP .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (14) :1658-1667

[9] Effect of screening and adjuvant therapy on mortality from breast cancer [J].

Berry, DA ;

Cronin, KA ;

Plevritis, SK ;

Fryback, DG ;

Clarke, L ;

Zelen, M ;

Mandelblatt, JS ;

Yakovlev, AY ;

Habbema, JDF ;

Feuer, EJ .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (17) :1784-1792

[10] Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: Preliminary results of the Italian Tamoxifen Anastrozole trial [J].

Boccardo, F ;

Rubagotti, A ;

Puntoni, M ;

Guglielmini, P ;

Amoroso, D ;

Fini, A ;

Paladini, G ;

Mesiti, M ;

Romeo, D ;

Rinaldini, M ;

Scali, S ;

Porpiglia, M ;

Benedetto, C ;

Restuccia, N ;

Buzzi, F ;

Franchi, R ;

Massidda, B ;

Distante, V ;

Amadori, D ;

Sismondi, P .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (22) :5138-5147

← 1 2 3 4 5 6 7 8 →